share_log

癌症和心脏病疫苗有望在2030年问世 这家公司已瞄准中国市场

Cancer and heart disease vaccines are expected to be introduced in 2030. This company is already targeting the Chinese market

Moomoo 24/7 ·  Apr 11, 2023 04:40
Paul Burton (Paul Burton), chief medical officer of the US vaccine manufacturer Moderna, recently revealed to the media that the company hopes to develop novel vaccines by 2030 to provide new solutions for diseases such as cancer and heart disease that could not be treated in the past. Moderna's latest forecast is consistent with German vaccine manufacturer BioNTech's previous statement. Moderna and BioNTech pioneered the development of a COVID-19 vaccine using the mRNA technology path during the COVID-19 pandemic, and pushed the mRNA vaccine into a golden age. BioNTech co-founder Ugur Sahin (Ugur Sahin) made a similar prediction in an interview with the media in October last year. At the time, he said, “The mRNA cancer vaccine may not be marketed until around 2030.” Moderna will hold an annual “Vaccine Day” event on April 11 and present the latest developments in vaccine development. (First Finance)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment